BIOMARKER:

HER-2 V777L

Entrez ID:

Related biomarkers:

‹

›

HER-2 V777L HER-2 V777L	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	neratinib Sensitive: C2 – Inclusion Criteria
HER-2 V777L HER-2 V777L	Breast Cancer Breast Cancer	trastuzumab Resistant: C3 – Early Trials
HER-2 V777L HER-2 V777L	Gastric Cancer Gastric Cancer	tucatinib Sensitive: D – Preclinical
HER-2 V777L HER-2 V777L	Breast Cancer Breast Cancer	ado-trastuzumab emtansine Resistant: D – Preclinical
HER-2 V777L HER-2 V777L	Colorectal Cancer CRC	trastuzumab + tucatinib Sensitive: D – Preclinical
HER-2 V777L HER-2 V777L	Colorectal Cancer CRC	tucatinib Sensitive: D – Preclinical
HER-2 V777L HER-2 V777L	Non Small Cell Lung Cancer NSCLC	tucatinib Sensitive: D – Preclinical
HER-2 V777L HER-2 V777L	Colorectal Cancer CRC	cetuximab Resistant: D – Preclinical
HER-2 V777L HER-2 V777L	Colorectal Cancer CRC	panitumumab Resistant: D – Preclinical

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

Associations